SHIKARI® Q-INFLIXI - Infliximab (Remicade®) ELISA
- 貨號 Cat. No.
- TR-Q-INFLIXIv1
- 規格 Size
- 12 x 8
- 品牌 Brand
- Matriks Biotek
Description
SHIKARI QS-INFLIXI & SHIKARI Q-INFLIXI & SHIKARI Q-ATI
SHIKARI QS-INFLIXI Instructions for Use PDF file
Enzyme immunoassay for the specific quantitative determination of Infliximab (Remicade®) in serum, plasma and other biological fluids.
Matriks Biotek Shikari Infliximab ELISA is developed for specific measurement of Infliximab (Remicade®) in sera, plasma and other biological fluids by the advantage of using a site-directed monoclonal antibody specific for Infliximab (Remicade®) only. The user-friendly Matriks Biotek shikari Specific Infliximab ELISA is the first and only ELISA kit for the quantitative determination of Infliximab (Remicade®) at uppermost specificity.
SHIKARI Q-INFLIXI Instructions for Use PDF file
Enzyme immunoassay for the quantitative determination of infliximab (Remicade®) in serum and plasma.
SHIKARI Q-ATI Instructions for Use PDF file
Enzyme immunoassay for the qualitative and quantitative determination of specific antibodies to infliximab in human serum and plasma.
“USE YOUR DRUG EFFECTIVELY AND SAFELY”
Follow-up your patient’s trough infliximab levels, dose response to infliximab with QS-INFLIXI and adjust dose when needed.
Check anti-infliximab antibodies in your patients sera with Q-ATI, escalate the dose or combine with (e.g.) methotrexate when needed.
| QS-INFLIXI | Q-INFLIXI | Q-ATI | |
|---|---|---|---|
Specific Infliximab(Remicade®)monoclonal based quantitative analyses | Free Infliximab (Remicade®)quantitative analyses | Infliximab(Remicade®)antibodies qualitative and quantitative analyses | |
Required Volume ( µl) | 10 | 10 | 10 |
Total Time (min) | 75 | 55 | 140 |
Sample | Serum, plasma and other biological fluids | Serum, plasma | Serum, plasma |
Sample Number | 96 | 96 | 96 |
Dedection Limit ( ng/mL) | 20 | 30 | 30 |
Spike Recovery (%) | 97 | 97 | 97 |
Shelf Life (year) | 1 | 1 | 1 |
同品牌其他產品